◆ Colray = Subsidiary of Deching Colray Nano Materials Research Institute Co., Ltd. incorporated
◆ Solgo Bio = KOSDAQ Market Committee decided to delist the stock
◆ Kyungnam Pharmaceutical = Decided to acquire Liveplex Tower in Nonhyeon-dong, Seoul for 41 billion KRW
◆ CN Plus = Partial repurchase of the 4th convertible bonds acquired before maturity
◆ Koyoung = Operating profit of 2.2 billion KRW in Q2, down 80.4% YoY
◆ Central Bio = Changed CEO to Lee Kang-hyun
◆ Entermate = Trading suspended from the 16th due to stock consolidation
◆ L&K Bio = Acquired patent rights related to anterior cervical plate
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025050713592847164_1746593968.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- 35% of Local Election Candidates Have Criminal Records...One in Three
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Jay Y. Lee Bows His Head: "I Will Take All the Blame"... Apologizes for Samsung Labor-Management Conflict
◆ InnoTherapy = Received product approval from Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) for in vitro hemostatic product (InnoSEAL)
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
